Research of Burden of Interstititial Lung Diseases in Turkey

NCT03995654 | Unknown

• 1 other identifier: 2018/176
• Study Type: observational
• Target: 1,000
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of our study is to investigate the etiological distribution of ILD, epidemiological characteristics of ILD cases such as age, gender, geography, smoking, occupation, economic status, education, and comorbidities. Another aim is to make the cost calculation from the first to the diagnosis in the patients diagnosed. Obtaining the missing data related to the ILD of our country is one of our goals.

Conditions

Lung Diseases, Interstitial; Fibrosis Lung

Keywords

Interstitial Lung Diseases; Fibrotic Lung; Prevalence

Outcome Measures

Primary Outcomes (9)

• Etiological distribution

  The aim of our study is to investigate the etiological distribution of ILD

  1 year

• Etiological distribution

  Geographic distribution of ILD patients according to regions (will be presented as %)

  1 year

• Epidemiological characteristics of ILD cases

  Age (years)

  1 year

• Epidemiological characteristics of ILD cases

  Gender (male, female; (will be presented as %))

  1 year

• Epidemiological characteristics of ILD cases

  Smoking (yes, no; (will be presented as %)

  1 year

• Epidemiological characteristics of ILD cases

  Distribution of ILD patients according to the occupation (will be presented as %)

  1 year

• Epidemiological characteristics of ILD cases

  Economic status (monthly salary of patients according to ILD types and stages of ILD)

  1 year

• Epidemiological characteristics of ILD cases

  Distiribution of ILD patienst according to comorbidities (will be presented as YES or NO and %) Comorbiditites are; Hypertension, Heart failure, Coronary Artery Disease, Arrhythmia, Heart Valve Disease, Asthma, COPD, Chronic Renal Disease, Diabetes Mellitus, Hyper / Hypothyroidism, HIV, Cirrhosis / Chronic Liver Disease, Lung malignancy, Extrapulmonary solid organ malignancy, Hematologic malignancy, SVO, Alzeimer, Epilepsy, Neuromuscular Ill, Organ Transplant Receiver, Reflux, Slyding hernia, Others

  1 year

• Total number

  We planned enroll roughly 1000 patients to the study

  1 year

Secondary Outcomes (10)

• Clinical findings

  1year

• Pulmonary functions

  1year

• Pulmonary functions

  1year

• Pulmonary functions

  1year

• Pulmonary functions

  1year

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

This study will be a multicenter prospective cross-sectional study in Turkey, that will be the coordinating center of our Department of Chest Diseases

You may qualify if:

• Patients who are not previously diagnosed with ILD will be included in the study.

You may not qualify if:

• under 18 years old
• older 80 years old

Sponsors & Collaborators

• Karadeniz Technical University: lead

Study Sites (1)

Department Of Chest Diseases, School Of medicine, Karadeniz Technical University

Trabzon, 61080, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Lung Diseases, Interstitial; Pulmonary Fibrosis

Condition Hierarchy (Ancestors)

Lung Diseases; Respiratory Tract Diseases; Fibrosis; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Target Duration: 1 Year
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: asst. prof.

Study Record Dates

• First Submitted: May 30, 2019
• First Posted: June 24, 2019
• Study Start: January 1, 2019
• Primary Completion: April 1, 2021
• Study Completion: May 1, 2021
• Last Updated: March 5, 2021

Record last verified: 2021-03

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)